1. Home
  2. ROIV vs CAE Comparison

ROIV vs CAE Comparison

Compare ROIV & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • CAE
  • Stock Information
  • Founded
  • ROIV 2014
  • CAE 1947
  • Country
  • ROIV United Kingdom
  • CAE Canada
  • Employees
  • ROIV N/A
  • CAE N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • CAE
  • Sector
  • ROIV Health Care
  • CAE
  • Exchange
  • ROIV Nasdaq
  • CAE Nasdaq
  • Market Cap
  • ROIV 8.4B
  • CAE 8.1B
  • IPO Year
  • ROIV N/A
  • CAE N/A
  • Fundamental
  • Price
  • ROIV $10.87
  • CAE $25.05
  • Analyst Decision
  • ROIV Buy
  • CAE Buy
  • Analyst Count
  • ROIV 4
  • CAE 3
  • Target Price
  • ROIV $17.50
  • CAE $32.33
  • AVG Volume (30 Days)
  • ROIV 5.2M
  • CAE 563.0K
  • Earning Date
  • ROIV 05-29-2025
  • CAE 05-13-2025
  • Dividend Yield
  • ROIV N/A
  • CAE N/A
  • EPS Growth
  • ROIV N/A
  • CAE N/A
  • EPS
  • ROIV N/A
  • CAE 0.88
  • Revenue
  • ROIV $122,585,000.00
  • CAE $3,275,402,649.00
  • Revenue This Year
  • ROIV N/A
  • CAE $8.43
  • Revenue Next Year
  • ROIV N/A
  • CAE $5.82
  • P/E Ratio
  • ROIV N/A
  • CAE $28.34
  • Revenue Growth
  • ROIV 140.04
  • CAE 9.93
  • 52 Week Low
  • ROIV $8.73
  • CAE $15.95
  • 52 Week High
  • ROIV $13.06
  • CAE $27.62
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 51.00
  • CAE 50.52
  • Support Level
  • ROIV $10.58
  • CAE $24.57
  • Resistance Level
  • ROIV $11.07
  • CAE $26.10
  • Average True Range (ATR)
  • ROIV 0.30
  • CAE 0.65
  • MACD
  • ROIV -0.04
  • CAE -0.13
  • Stochastic Oscillator
  • ROIV 30.21
  • CAE 42.55

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Share on Social Networks: